Psoriasis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Sapan Patel (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Psoriasis}} | {{Psoriasis}} | ||
{{CMG}} | |||
==Overview== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 23:52, 29 July 2020
|
Psoriasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Psoriasis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Psoriasis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Psoriasis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]